GSK Plc (GSK)
54.47
+0.25
(+0.46%)
USD |
NYSE |
Apr 28, 16:00
52.25
-2.22
(-4.08%)
Pre-Market: 07:34
GSK Research and Development Expense (TTM) : 9.632B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| AstraZeneca PLC | 13.84B |
| Biodexa Pharmaceuticals Plc | 5.234M |
| Novavax, Inc. | 338.72M |
| BioNTech SE | 2.379B |
| Moderna, Inc. | 2.917B |